Le Lézard
Classified in: Health
Subject: AVO

Acadiana Dermatology & ajeuné Medspa Expanding Aesthetic Services To Meet Growing Lafayette Market Demand


LAFAYETTE, La., Jan.17, 2018 /PRNewswire-PRWeb/ -- Acadiana Dermatology and ajeuné Medspa is adding to its aesthetic services to accommodate its rapidly growing patient base in the greater Lafayette market.

The practice is responding to this demand in several ways. For the first time, evening hours soon will be added to the weekday schedule to accommodate those in need of after-hours cosmetic services. ajeuné medspa has added another esthetician to its highly experienced team, welcoming back Ms. Leslie Whittington. Leslie is a Lafayette native and a licensed medical Esthetician who has served hundreds of patients with over ten years of expertise in laser hair removal, laser and other skincare treatments. In addition, the Practice has added the most advanced body contouring program in the Lafayette market. Launching at their February 1st Evening of Beauty event. The Practice will now offer both CoolSculpting and ZWave for non- surgical removal of excess body and facial fat.

"My team and I are responding to our patients' ever-growing cosmetic needs," Dr. Chris Hubbell said. "We are creating additional office hours, welcoming back one of Lafayette's most experienced Estheticians and investing in clinically proven state-of-the-art non-invasive body shaping technology to better accommodate our valued patients demand."

For more information, and to RSVP to our CoolSculpting event, please go to http://www.skinexpert.com or call (337) 989-7272.

 

SOURCE Acadiana Dermatology


These press releases may also interest you

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...

18 avr 2024
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: